Neuro-Oncology

Top Story

10 updates in immunotherapy research

June 23, 2017

In recognition of Cancer Immunotherapy Month, Cancer Research Institute has organized a series of educational and social events designed to raise awareness regarding these treatment options.

In conjunction with their efforts, HemOnc Today presents 10 updates in immunotherapy treatment and research that may affect your practice.

High-dose vitamin C may increase efficacy of cancer therapies

June 23, 2017
The addition of high-dose vitamin C to standard chemotherapy or radiation appeared to effective and safe for patients with glioblastoma multiforme and non–small…
In the Journals Plus

Cost of hospital-based end-of-life care high for elderly with brain tumors

June 22, 2017
Hospital-based end-of-life care for elderly patients with malignant brain tumors is associated with up to $16,000 in expenses, according to a research letter published…
FDA News

FDA approves optical imaging agent to assist in resection of high-grade glioma

June 22, 2017
The FDA approved aminolevulinic acid hydrochloride as an optical imaging agent indicated for patients with gliomas as an adjunct for the visualization of malignant…
CME

Polycythemia Vera: Aligning Real World Practices With Current Best Practices

This activity is supported by an independent educational grant from Incyte Corporation.

Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to…
More »
Video
Meeting News

VIDEO: Precision medicine, immunotherapy show promise in neuro-oncology research

June 8, 2017
More »
Featured
ASCO Annual Meeting

ASCO Annual Meeting

CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »

10 updates in immunotherapy research

June 23, 2017
In recognition of Cancer Immunotherapy Month, Cancer Research Institute has organized a series of educational and social events designed to raise…

High-dose vitamin C may increase efficacy of cancer therapies

June 23, 2017
The addition of high-dose vitamin C to standard chemotherapy or radiation appeared to effective and safe for patients with glioblastoma multiforme…

In the Journals Plus

Cost of hospital-based end-of-life care high for elderly with brain tumors

June 22, 2017
Hospital-based end-of-life care for elderly patients with malignant brain tumors is associated with up to $16,000 in expenses, according to a…

FDA News

FDA approves optical imaging agent to assist in resection of high-grade glioma

June 22, 2017
The FDA approved aminolevulinic acid hydrochloride as an optical imaging agent indicated for patients with gliomas as an adjunct for the…

Geneticist to lead Vanderbilt cancer center’s health disparities program

June 19, 2017
Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center. Pal, a clinical geneticist…

10 highlights from the ASCO Annual Meeting

June 16, 2017
This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.” …

Researchers assess pinworm medication for adults, children with glioblastoma

June 15, 2017
Researchers at Johns Hopkins University are conducting the first clinical trials to evaluate the potential of a pinworm medication for the treatment…

Oral contraceptive use does not increase long-term cancer risk

June 14, 2017
Women who used oral contraceptives did not demonstrate increased long-term cancer risk, according to results of the Royal College of General…

Meeting NewsVideo

VIDEO: Visiting expert program helps community providers learn about immuno-oncology

June 12, 2017
CHICAGO — Jarushka Naidoo, MBBCh, spoke with HemOnc Today at the ASCO Annual Meeting about the Institute for Clinical Immuno-Oncology. The…

FDA News

FDA grants breakthrough therapy designation to burtomab for pediatric neuroblastoma

June 12, 2017
The FDA granted breakthrough therapy designation to burtomab for the treatment of pediatric patients with relapsed or refractory neuroblastoma who…

More Headlines »
Advertisement
Advertisement